Cargando…
Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice
BACKGROUND: Despite considerable progress in the development of anticancer therapies, there is still a high mortality rate caused by cancer relapse and metastasis. Dormant or slow-cycling residual tumor cells are thought to be a source of tumor relapse and metastasis, and are therefore an obstacle t...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568736/ https://www.ncbi.nlm.nih.gov/pubmed/23270473 http://dx.doi.org/10.1186/1741-7015-10-172 |